Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

PURPOSE: Patients with advanced pancreas cancer present with disease that is poorly responsive to conventional therapies. Preclinical and early clinical evidence has supported targeting the epidermal growth factor receptor (EGFR) signaling pathway in patients with pancreas cancer. This trial was con...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Philip, Philip A., Benedetti, Jacqueline, Corless, Christopher L., Wong, Ralph, O'Reilly, Eileen M., Flynn, Patrick J., Rowland, Kendrith M., Atkins, James N., Mirtsching, Barry C., Rivkin, Saul E., Khorana, Alok A., Goldman, Bryan, Fenoglio-Preiser, Cecilia M., Abbruzzese, James L., Blanke, Charles D.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2010
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2917315/
https://ncbi.nlm.nih.gov/pubmed/20606093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.7550
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars